Table 1.
N total (130) |
IL‐35 expression Poor (69) Rich (61) |
χ 2 | P value | |
---|---|---|---|---|
Age | 1.668 | 0.214 | ||
< 55 | 52 | 24 | 28 | |
≥ 55 | 78 | 45 | 33 | |
Sex | 0.02 | 1.000 | ||
Men | 37 | 20 | 17 | |
Women | 93 | 49 | 44 | |
Smoking | 0.722 | 0.449 | ||
Yes | 90 | 50 | 40 | |
No | 40 | 19 | 21 | |
Differentiation | 6.842 | 0.014 | ||
Moderate + well | 63 | 26 | 37 | |
Poor | 67 | 43 | 24 | |
Lymph node metastasis | 8.436 | 0.005 | ||
Absence (N0) | 58 | 39 | 19 | |
Presence (N+) | 72 | 30 | 42 | |
T stage | 7.000 | 0.03 | ||
T1 | 61 | 31 | 30 | |
T2 | 32 | 23 | 9 | |
T3 | 37 | 15 | 22 | |
LVD | 6.002 | 0.022 | ||
Low | 66 | 42 | 24 | |
High | 64 | 27 | 37 | |
MVD | 4.494 | 0.037 | ||
Low | 64 | 40 | 24 | |
High | 66 | 29 | 37 |
IL‐35, interleukin‐35; LVD, lymphatic vessel density; MVD, microvessel density; NSCLC, non‐small cell lung cancer.